FDA
-
-
-
-
-
-
-
Rein Therapeutics publishes study data on LTI-03 for lung fibrosis
-
-
-
-
-
-
-
Brookline Capital Markets Downgrades Rein Therapeutics (RNTX) to Hold
-
-
-
-
-
-
-
Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F
-
-
-
330,132 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

